MedPath
NMPA Approval

Teclistamab Injection

国药准字SJ20240026

June 18, 2024

Drug Information

特立妥单抗注射液

泰立珂

注射剂

153 mg(1.7ml)/瓶

生物制品

June 18, 2024

June 17, 2029

Company Information

Applicant Company

Turnhoutseweg 30, B-2340 Beerse, Belgium

Manufacturing Company

5900 Martin Luther King Jr. Hwy, Greenville, NC 27834, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

特立妥单抗注射液 - NMPA 批准文号 | MedPath